<DOC>
	<DOCNO>NCT00897169</DOCNO>
	<brief_summary>This trial conduct Europe Japan . The aim clinical trial investigate possible difference development type 2 diabetes Japanese Caucasian population . Healthy subject , subject impair glucose tolerance , well subject type 2 diabetes include trial . The development type 2 diabetes across cohort investigate regard insulin sensitivity B-cell capacity .</brief_summary>
	<brief_title>A Trial Investigating Possible Difference Development Type 2 Diabetes Between Caucasian Japanese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Danish ( Northern European ) Japanese ( accord country allocation ) background least 3 generation BMI equal 18 kg/m2 Treatment diabetes mellitus insulin product Fasting plasma/serum glucose 12 mM Therapy TZD ( thiazolidinedione ) drug within past 3 month Therapy 2 OADs ( oral antidiabetic drug )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>